Safe Use of Augmentin in Nephrotic Syndrome

Introduction to Augmentin Safety

• The Kidney International guidelines recommend assessing current GFR before prescribing Augmentin to nephrotic syndrome patients, as many will have preserved renal function and can receive standard dosing 1
• The Kidney International guidelines emphasize careful monitoring of renal function in nephrotic syndrome patients, including monitoring for acute kidney injury 1

Drug Interactions and Monitoring

• The Kidney International guidelines state that no significant interaction exists between Augmentin and ACE inhibitors or ARBs, which are commonly used as first-line therapy for proteinuria and hypertension in nephrotic patients 1
• The Kidney International guidelines recommend counseling patients to hold diuretics when at risk for volume depletion, which could compound any nephrotoxic risk from antibiotics 1
• The Kidney International guidelines recommend monitoring INR more frequently when starting Augmentin in patients on warfarin for thromboprophylaxis, as antibiotics can potentiate warfarin effects and increase bleeding risk 2

Clinical Monitoring and Dosing

• The Kidney International guidelines recommend checking serum creatinine before and during treatment, especially if baseline GFR is compromised, to monitor renal function 1
• The Kidney International guidelines recommend assessing volume status to ensure adequate hydration and prevent hypovolemia, which can increase the risk of drug-induced AKI 1
• The Kidney International guidelines recommend checking INR within 3-5 days of starting antibiotic in patients on warfarin 2